Genmab A/S (Nasdaq: GMAB) and AbbVie (NYSE: ABBV) have clarified that overall survival was the sole U.S. primary endpoint in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE